The new BioMed X research team, led by neuroscientist Dr. Kevin Michael Keary III, will investigate the brain circuit mechanisms underlying anhedonia to identify biomarkers and potential therapeutic targets. New Haven, CT, USA, September 29, 2026 – BioMed X, a leading innovation engine for pharma, today announced the start of a new research team in […]
Maria Morganti
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 14
- Comments 0